Literature DB >> 20977932

Layer-specific activity of tissue non-specific alkaline phosphatase in the human neocortex.

L Négyessy1, J Xiao, O Kántor, G G Kovács, M Palkovits, T P Dóczi, L Renaud, G Baksa, T Glasz, M Ashaber, P Barone, C Fonta.   

Abstract

The ectoenzyme tissue non-specific alkaline phosphatase (TNAP) is mostly known for its role in bone mineralization. However, in the severe form of hypophosphatasia, TNAP deficiency also results in epileptic seizures, suggesting a role of this enzyme in brain functions. Accordingly, TNAP activity was shown in the neuropil of the cerebral cortex in diverse mammalian species. However in spite of its clinical significance, the neuronal localization of TNAP has not been investigated in the human brain. By using enzyme histochemistry, we found an unprecedented pattern of TNAP activity appearing as an uninterrupted layer across diverse occipital-, frontal- and temporal lobe areas of the human cerebral cortex. This marked TNAP-active band was localized infragranulary in layer 5 as defined by quantitative comparisons on parallel sections stained by various techniques to reveal the laminar pattern. On the contrary, TNAP activity was localized in layer 4 of the primary visual and somatosensory cortices, which is consistent with earlier observations on other species. This result suggests that the expression of TNAP in the thalamo-recipient granular layer is an evolutionary conserved feature of the sensory cortex. The observations of the present study also suggest that diverse neurocognitive functions share a common cerebral cortical mechanism depending on TNAP activity in layer 5. In summary, the present data point on the distinctive role of layer 5 in cortical computation and neurological disorders caused by TNAP dysfunctions in the human brain.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20977932     DOI: 10.1016/j.neuroscience.2010.10.049

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  23 in total

1.  Serum alkaline phosphatase is elevated and inversely correlated with cognitive functions in subjective cognitive decline: results from the ReGAl 2.0 project.

Authors:  Virginia Boccardi; Valentina Bubba; Ilenia Murasecco; Martina Pigliautile; Roberto Monastero; Roberta Cecchetti; Michela Scamosci; Patrizia Bastiani; Patrizia Mecocci
Journal:  Aging Clin Exp Res       Date:  2020-05-03       Impact factor: 3.636

2.  Analysis of vascular homogeneity and anisotropy on high-resolution primate brain imaging.

Authors:  Pol Kennel; Caroline Fonta; Romain Guibert; Franck Plouraboué
Journal:  Hum Brain Mapp       Date:  2017-08-28       Impact factor: 5.038

3.  Gene expression and response prediction to amisulpride in the OPTiMiSE first episode psychoses.

Authors:  Réjane Troudet; Wafa Bel Haj Ali; Delphine Bacq-Daian; Inge Winter van Rossum; Anne Boland-Auge; Christophe Battail; Caroline Barau; Dan Rujescu; Philip McGuire; René S Kahn; Jean-François Deleuze; Marion Leboyer; Stéphane Jamain
Journal:  Neuropsychopharmacology       Date:  2020-05-25       Impact factor: 7.853

Review 4.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

5.  Infantile hypophosphatasia secondary to a novel compound heterozygous mutation presenting with pyridoxine-responsive seizures.

Authors:  Dina Belachew; Traci Kazmerski; Ingrid Libman; Amy C Goldstein; Susan T Stevens; Stephanie Deward; Jerry Vockley; Mark A Sperling; Arcangela L Balest
Journal:  JIMD Rep       Date:  2013-03-12

6.  Reduced striatal ecto-nucleotidase activity in schizophrenia patients supports the "adenosine hypothesis".

Authors:  Elisabet Aliagas; Izaskun Villar-Menéndez; Jean Sévigny; Mercedes Roca; Miriam Romeu; Isidre Ferrer; Mireia Martín-Satué; Marta Barrachina
Journal:  Purinergic Signal       Date:  2013-06-16       Impact factor: 3.765

Review 7.  Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.

Authors:  Jean Pierre Salles
Journal:  Clin Biochem Rev       Date:  2020-02

8.  Ablation of TNAP function compromises myelination and synaptogenesis in the mouse brain.

Authors:  János Hanics; János Barna; Jinsong Xiao; José Luis Millán; Caroline Fonta; László Négyessy
Journal:  Cell Tissue Res       Date:  2012-06-14       Impact factor: 5.249

9.  Identification of altered brain metabolites associated with TNAP activity in a mouse model of hypophosphatasia using untargeted NMR-based metabolomics analysis.

Authors:  Thomas Cruz; Marie Gleizes; Stéphane Balayssac; Etienne Mornet; Grégory Marsal; José Luis Millán; Myriam Malet-Martino; Lionel G Nowak; Véronique Gilard; Caroline Fonta
Journal:  J Neurochem       Date:  2017-03       Impact factor: 5.372

10.  Successful gene therapy in utero for lethal murine hypophosphatasia.

Authors:  Hanako Sugano; Tae Matsumoto; Koichi Miyake; Atsushi Watanabe; Osamu Iijima; Makoto Migita; Sonoko Narisawa; José Luis Millán; Yoshitaka Fukunaga; Takashi Shimada
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.